These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 20145606
1. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Am J Gastroenterol; 2010 Aug; 105(8):1893-900. PubMed ID: 20145606 [Abstract] [Full Text] [Related]
2. TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease. Levine A, Shamir R, Wine E, Weiss B, Karban A, Shaoul RR, Reif SS, Yakir B, Friedlander M, Kaniel Y, Leshinsky-Silver E. Am J Gastroenterol; 2005 Jul; 100(7):1598-604. PubMed ID: 15984988 [Abstract] [Full Text] [Related]
3. [Malnutrition and growth retardation in children and adolescents with Crohn's disease]. Naveh Y. Harefuah; 1999 May 02; 136(9):726-9. PubMed ID: 10955099 [No Abstract] [Full Text] [Related]
4. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease. Sawczenko A, Ballinger AB, Savage MO, Sanderson IR. Pediatrics; 2006 Jul 02; 118(1):124-9. PubMed ID: 16818557 [Abstract] [Full Text] [Related]
7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May 02; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
8. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status. Trebble TM, Wootton SA, Stroud MA, Mullee MA, Calder PC, Fine DR, Moniz C, Arden NK. Aliment Pharmacol Ther; 2004 May 15; 19(10):1063-71. PubMed ID: 15142195 [Abstract] [Full Text] [Related]
9. The prevalence of malnutrition and the evolution of nutritional status in patients with moderate to severe forms of Crohn's disease treated with Infliximab. Vadan R, Gheorghe LS, Constantinescu A, Gheorghe C. Clin Nutr; 2011 Feb 15; 30(1):86-91. PubMed ID: 20719413 [Abstract] [Full Text] [Related]
10. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H. Nutrition; 2008 Feb 15; 24(7-8):694-702. PubMed ID: 18499398 [Abstract] [Full Text] [Related]
11. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group. Gut; 2008 Nov 15; 57(11):1518-23. PubMed ID: 18566104 [Abstract] [Full Text] [Related]
12. The real cost of pediatric Crohn's disease: the role of infliximab in the treatment of pediatric IBD. Kay M, Wyllie R. Am J Gastroenterol; 2003 Apr 15; 98(4):717-20. PubMed ID: 12738445 [No Abstract] [Full Text] [Related]
13. Symposium 6: Young people, artificial nutrition and transitional care: Nutrition, growth and puberty in children and adolescents with Crohn's disease. Beattie RM. Proc Nutr Soc; 2010 Feb 15; 69(1):174-7. PubMed ID: 19968909 [Abstract] [Full Text] [Related]
14. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Wine E, Reif SS, Leshinsky-Silver E, Weiss B, Shaoul RR, Shamir R, Wasserman D, Lerner A, Boaz M, Levine A. Pediatrics; 2004 Nov 15; 114(5):1281-6. PubMed ID: 15520108 [Abstract] [Full Text] [Related]
15. The operative treatment of Crohn's disease in childhood. Block GE, Moossa AR, Simonowitz D. Surg Gynecol Obstet; 1977 May 15; 144(5):713-7. PubMed ID: 850855 [Abstract] [Full Text] [Related]
16. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Kirschner BS, Klich JR, Kalman SS, deFavaro MV, Rosenberg IH. Gastroenterology; 1981 Jan 15; 80(1):10-5. PubMed ID: 6778756 [Abstract] [Full Text] [Related]
17. Crohn's disease and growth deficiency in children and adolescents. Gasparetto M, Guariso G. World J Gastroenterol; 2014 Oct 07; 20(37):13219-33. PubMed ID: 25309059 [Abstract] [Full Text] [Related]
18. Growth failure in children and adolescents with Crohn's disease. Tietjen K, Behrens R, Weimann E. Turk J Gastroenterol; 2009 Mar 07; 20(1):13-9. PubMed ID: 19330730 [Abstract] [Full Text] [Related]
19. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease. Sinitsky DM, Lemberg DA, Leach ST, Bohane TD, Jackson R, Day AS. J Gastroenterol Hepatol; 2010 Apr 07; 25(4):810-6. PubMed ID: 20492339 [Abstract] [Full Text] [Related]
20. Treatment of growth retardation in childhood Crohn's disease. Stewart JT, Pennington CR. Br J Clin Pract; 1986 Dec 07; 40(12):503-7. PubMed ID: 3651296 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]